Van den Bergh PYK, van Doorn PA, Hadden RDM, et al. European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force-Second revision. J Peripher Nerv Syst. 2021 Sep;26(3):242-268. doi: 10.1111/jns.12455. PMID: 34085743.
Toyka KV, Gold R. The pathogenesis of CIDP: rationale for treatment with immunomodulatory agents. Neurology. 2003 Apr 1;60(8 Suppl 3):2-7.
Lewis R. A. Chronic inflammatory demyelinating polyneuropathy //Neurologic clinics. 2007. Т. 25. №. 1. С. 71-87.
Cornblath D. R. et al. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies //Journal of neuroimmunology. 1990. Т. 26. №. 2. С. 113-118.
Schmidt B. et al. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy //Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine.–1996.–Т.19. №.4. С.474-487.
Pollard J. D. et al. Activated T cells of nonneural specificity open the blood nerve barrier to circulating antibody //Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society. 1995. Т. 37. №. 4. С. 467-475.
Dalakas M. C., Engel W. K. Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy //Archives of neurology. 1980. Т. 37. №. 10. С. 637-640.
Mathey E. K. et al. Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype //J Neurol Neurosurg Psychiatry.–2015.–Т. 86.–№. 9. С. 973-985.
Dyck P. J. B., Tracy J. A. History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy //Mayo Clinic Proceedings. Elsevier, 2018. Т. 93. №. 6. С. 777-793.
Querol L. et al. Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy //Annals of neurology. 2013. Т. 73. №. 3. С. 370-380.
Doppler K. et al. Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies //J Neurol Neurosurg Psychiatry. 2015. Т. 86. №. 7. С. 720-728.
Querol L. et al. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg //Neurology. 2014. Т. 82. №. 10. С. 879-886.
Uncini A., Vallat J. M. Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground //J Neurol Neurosurg Psychiatry. 2018. Т. 89. №. 6. С. 627-635.
Delmont E. et al. Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy //Brain. 2017. Т. 140. №. 7. С. 1851-1858.
Broers M.C., Bunschoten C. Incidence and Prevalence of Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Systematic Review and Meta-Analysis. Neuroepidemiology 2019;52:161–172
Rajabally Y.A., Simpson B.S., Beri S. et al. Epidemiologic variability of chronic inflammatory demyelinating polyneuropathy with different diagnostic criteria: study of a UK population. Muscle Nerve 2009;39(4):432–8.
Попова Т.Е., Шнайдер Н.А., Петрова М.М., Николаева Т.Я., Кантимирова Е.А. Эпидемиология хронической воспалительной демиелинизирующей полиневропатии за рубежом и в России. Нервно-мышечные болезни. 2015;5(2):10-15. [Popova T.E., Shnayder N.A., Petrova M.M., Nikolaeva T.Y., Kantimirova E.A. Epidemiology of chronic inflammatory demyelinating polyneuropathy abroad and in Russia. Neuromuscular Diseases. 2015;5(2):10-15. (In Russ.)].
Супонева Н.А, Никитин С.С., Пирадов М.А., Меркулова Д.М. Хроническая воспалительная демиелинизирующая полиневропатия с острым началом и дыхательной недостаточностью. Нервные болезни 2007;(1):40–4. [Suponeva N.A., Nikitin S.S., Piradov M.A., Merkulova D.M. Chronic inflammatory demyelinating polyneuropathy with acute onset and respiratory failure. Nervnye bolezni = Nervous Diseases 2007;(1):40–4. (In Russ.)].
Lehmann H. C., Burke D., Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment //J Neurol Neurosurg Psychiatry. 2019. С. jnnp-2019-320314.
Viala K. et al. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy //Journal of the peripheral nervous system. 2010. Т. 15. №. 1. С. 50-56.
Rajabally Y. A., Chavada G. Lewis–Sumner syndrome of pure upper-limb onset: Diagnostic, prognostic, and therapeutic features //Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine. 2009. Т. 39. №. 2. С. 206-220.
Ayrignac X. et al. Sensory chronic inflammatory demyelinating polyneuropathy: an under- recognized entity? //Muscle & nerve. 2013. Т. 48. №. 5. С. 727-732.
Katz J. S. et al. Distal acquired demyelinating symmetric neuropathy //Neurology. 2000. Т. 54. №. 3. С. 615-615.
Ruts L. et al. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study //Neurology. 2010. Т. 74. №. 21. С. 1680-1686.
Kimura A, Sakurai T, Koumura A et al. Motor - dominant chronic inflammatory demyelinating polyneuropathy. JNeurol. 2010;257(4):621- 9.
Devaux J. J. et al. Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy //Neurology. 2016. Т. 86. №. 9. С. 800-807.
Roach С., Pasnoor М. et al. Evaluation of CIDP Diagnostic Criteria and Treatment Responses. Neurology Apr 2016, 86 (16 Supplement) P3.141
Rajabally YA, Nicolas G, Piéret F, Bouche P, Van den Bergh PY. Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1364-8.
Viala K., Maisonobe T. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry. 2009 Dec;80(12):1364-8.
Gorson K.C. An update on the management of chronic inflammatory demyelinating polyneuropathy // Ther. Adv. Neurol. Disord. 2012. Vol 5. P. 359-373